We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Eduardo Tolosa

Eduardo Tolosa MD

Professor of Neurology; Director of the Parkinson Disease Research Program at the University of Barcelona Hospital

Eduardo Tolosa obtained his MD degree from the University of Barcelona and received his neurological training at the University of Minnesota Hospital in Minneapolis. Prof. Tolosa was certified as a neurologist by the American Board of Neurology and Psychiatry and is currently Professor of Neurology at the University of Barcelona  and  Director of the Parkinson Disease Research Program  at the University of Barcelona Hospital. He is a founding member and past president of the Movement Disorder Society. He is also past president of the European Neurological Society.  He is the recipient of the  American Academy of Neurology  2014 Movement Disorders Research Award.

Professor Tolosa’s research interests are in movement disorders. He was involved in pioneering studies defining the mechanisms underlying levodopa-related motor fluctuations and  the role of DAT SPECT in the diagnosis of Parkinson disease  and his team has been among the first in Europe to evaluate the efficacy of novel surgical strategies for Parkinson’s disease, such as subthalamic nucleus stimulation, subcutaneous dopamine agonist infusions and intraduodenal infusions of levodopa. Other areas of current research include assessment of non-motor  symptoms in asymptomatic  carriers of Parkinson-associated  genetic mutations and the study of diagnostic  biomarkers in premotor of Parkinson disease.